Innovation in Health Technology & Research
AI Powered Prediction Tools for Improved Health Outcomes
MindBio conducts research & clinical trials and uses data collected to develop prediction technologies to optimise human health and wellness.
The Company has expertise in clinical trials and has made major discoveries related to the human voice and predicting health outcomes.
In a world first, MindBio has developed an intoxication detection technology that uses artificial intelligence, advanced machine learning techniques and the human voice to predict performance impairment and blood alcohol concentration.
The Human Voice as a Predictive Biomarker for Health
Health & Wellness Prediction Tools
AI Powered Prediction Technologies for Improved Health Outcomes.
We have been featured in:
Clinical Trials
The Company has expertise in completing randomised controlled trials and research.
The Company takes the data collected from research to develop medicines and build prediction tools to optimise human health and wellness.
The Company has conducted clinical trials and research in microdosing of lysergic acid diethylamide and alcohol intoxication.
Ongoing Updates
The Company is pleased to announce it has developed the world’s first prediction tool for alcohol intoxication using Artificial Intelligence, Machine Learning and human voice analysis.
The Company’s first consumer web and mobile application was launched in 2025 and the Company is developing enterprise solutions in Human Voice Analysis and drug and alcohol intoxication.
Awarded:
Company of the Year
— Annual Microdose Awards, Miami 2022
A brighter future for mental health.
— MindBio Therapeutics mission
SmallCap Investor interviews CEO Justin Hanka.
MindBio Therapeutics CEO Justin Hanka is interviewed by Joe Brunner. The interview is in English but note that the opening 66 seconds of show begins in German.
MindBio Therapeutics Co-founder Justin Hanka is interviewed by Joe Brunner at Smallcap Investor in Europe.
MindBio is listed on the CSE
Watch the InvestmentPitch Media video announcing the public listing of MindBio Therapeutics on the Canadian Stock Exchange on 5 May 2023. MindBio is trading. More here.
Announcing MindBio’s listing on the CSE
A fascinating history of LSD in Medicine.
Watch our short explainer film regarding the fascinating history of LSD in medicine and how psychedelics act to change the way the brain works.
A fascinating history of LSD in medicine
Meet our team
Gavin Upiter. BEng. (Chairman), is a serial pharmaceutical entrepreneur with over 25 years experience in the industry. Prior to founding Generic Health, a leading generic pharmaceutical company which was sold to Lupin Pharmaceuticals, (NSE: LUPIN), Gavin started his executive career at Bristol Myers Squibb. He was Australian CEO of Amneal Pharmaceuticals (NYSE: AMRX) and Executive Director of Slade Health, Australia’s leading hospital pharmacy chain. Gavin founded Directo, Australia’s first online pharmaceutical B2B marketplace for pharmacies and suppliers.
Dr Zena Burgess (Non executive director ) has over 25 years experience working in mental health areas as a clinical and organizational psychologist . She has also worked as an executive and consultant in the health industry. Zena is former CEO of the Royal Australian College of General Practitioners ( RACGP) and is currently CEO of the Australian Psychological Society( APS) which is the peak organisation for psychologists in Australia. She has been recognised by Fellowships of AICD and APS.
Justin Hanka (Co-Founder & Chief Executive Officer) is an investment banker with expertise in M&A and capital markets transactions & IPO’s in Australia and Nth America. He is Non-Executive Director of EonX (CSE: EONX), a financial technology company, Non-Executive Chair of SPARC AI Inc (CSE:SPAI) Non-Executive Chairman of Blackhawk Growth Corp (CSE: BLR) and Co-Founder of Merchant Bank Hardenbrook Group and multiple portfolio companies. Justin was recently voted Entrepreneur of the Year and Innovator of the Year at the leading industry awards.
“Mood disorders are a leading cause of health loss, however current treatments do not work or are not well tolerated by large numbers of people who suffer.”
— Health Research Council of New Zealand. Grant Summary of Purpose.